Alyeska Investment Group
FLAC

Alyeska Investment Group’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Alyeska Investment Group’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,287
Closed -$282K – 544
2022
Q3 		$282K Sell
28,287
-725,205
-96% -$7.2M ﹤0.01% 371
2022
Q2 		$7.44M Hold
753,492
– – 0.09% 247
2022
Q1 		$7.41M Hold
753,492
– – 0.08% 249
2021
Q4 		$7.35M Hold
753,492
– – 0.08% 225
2021
Q3 		$7.4M Hold
753,492
– – 0.09% 251
2021
Q2 		$7.35M Buy
753,492
+38,490
+5% +$380K 0.09% 268
2021
Q1 		$7.12M Buy
+715,002
New +$7.3M 0.09% 262

Alyeska Investment Group's FLAC Position: Q4 2022 in Review

Alyeska Investment Group sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 28,287 shares — an estimated $282K sold.

Alyeska Investment Group first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $7.44M in Q2 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

  • Alyeska Investment Group reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 28,287 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $282K.
  • Alyeska Investment Group first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
  • Alyeska Investment Group's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $7.44M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.